VR Logo

BioDelivery Sciences International Inc (BDSI) download report


Healthcare | Drugs & Pharma

BioDelivery Sciences International Inc (BDSI) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally.

IPO Date: 25-Jul-2002

CEO & Director: Mr. Jeffrey Allen Bailey

Pres & Chief Commercial Officer: Mr. Scott M. Plesha

Listing: NASDAQ: BDSI

Country: United States

Headquarters: Raleigh, NC

Website: https://www.bdsi.com

Key Facts

Market cap: $577.05 Mln

Revenue (TTM): $84.17 Mln

Earnings (TTM): $84.86 Mln

Cash: $114.31 Mln

Total Debt: $4.62 Mln

Insider's Holding: 7.58%

Liquidity: Low

52 Week range: $2.50 - 5.62

Shares outstanding: 103,229,000

10 Years Aggregate:

  • CFO: $-113.94 Mln
  • EBITDA: $-124.69 Mln
  • Net Profit: $-148.09 Mln

Stock Performance

Time Period BioDelivery Sciences International Inc (BDSI) S&P BSE Sensex* S&P BSE Healthcare*
YTD80.32-8.62-17.06
1 month0.72-4.54-1.40
3 months81.49-10.19-10.77
1 Year49.071.43-16.41
3 Years1.7910.1418.88
5 Years24.4211.268.85
10 Years8.7311.8212.13
As on 31-Mar-2022 *As on 04-Jul-2022
Year BioDelivery Sciences International Inc (BDSI) S&P BSE Sensex S&P BSE Healthcare
2021-26.1921.9920.87
2020-33.5415.7561.45
201970.8114.38-3.55
201825.275.87-5.89
201768.5727.910.49
2016-63.471.95-12.88
2015-60.15-5.0315.06